Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)

Journal article

Peer reviewed

I A Mayer, B Jovanovic, V G Abramson, E L Mayer, M E Sanders, A Bardia, P M Dillon, M G Kuba, J T Carpenter, J C Chang, …

Cancer research (Chicago, Ill.), Vol.73(24 Supplement), pp.PD1-6-PD1-6

2013-12-15

Metrics

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.119 Breast Cancer Scanning; 1.119.259 HER2
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)
Creators: I A Mayer
B Jovanovic
V G Abramson
E L Mayer
M E Sanders
A Bardia
P M Dillon
M G Kuba
J T Carpenter
J C Chang
B D Lehmann
I M Meszoely
A Grau
Y Shyr
C L Arteaga
X(S) Chen
J A Pietenpol
Publication Details: Cancer research (Chicago, Ill.), Vol.73(24 Supplement), pp.PD1-6-PD1-6
Language: English
Resource Type: Journal article
Record Identifier: 991031600431402976